Displaying 1–17 of 17 results for Venture Development Corp
If it cant be measured, it cant be green; leading manufacturers are turning to advanced metrics to show just how sustainable their products, processes, and plants really are.
The global market for pharmaceutical contract manufacturing witnessed robust growth in recent years, and the future continues to hold tremendous prospects for the industry.
As FDA probes the connection between workforce training and quality, manufacturers must do the same.
Next Fall, Novavax expects to move to Phase III testing of its seasonal flu vaccine. In the meantime, its refining a manufacturing process that uses disposable process equipment to minimize risk, cost and plant footprint. VP Jim Robinson discusses the companys plans.
Executives at nearly 450 global drug manufacturers weigh in on whats troubling them now, and what challenges face them ahead.
The companys loss may, in the end, be industrys gain as entrepreneurs start their own ventures.
In a year when 'change' is the watchword in politics, even a key pharmaceutical industry trade show seems to have caught change fever. Philadelphia will surely benefit; what can attendees look forward to?
Contract research is both a vehicle for Chinese pharmas to expand their R&D expertise and quality levels, and a bridge for them to enter global markets.
The North American market for wireless monitoring and control products is taking off. This paper by Venture Development Corp. tells which direction its headed.
The future is now for process monitoring via wireless instrumentation, while wireless process control looms.
By providing a direct, real-time connection to any pharmaceutical processing and APC platforms, Process Analytical Technology (PAT) opens up new possibilities for manufacturers.